Free Trial
OTCMKTS:ACUR

Acura Pharmaceuticals (ACUR) Stock Price, News & Analysis

Acura Pharmaceuticals logo
$0.0002 0.00 (0.00%)
As of 07/3/2025

About Acura Pharmaceuticals Stock (OTCMKTS:ACUR)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.00
$0.02
52-Week Range
$0.00
$0.75
Volume
N/A
Average Volume
2,375 shs
Market Capitalization
$13.30 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ACUR Stock News Headlines

Acura Pharma Stock Price History - Investing.com
Acura Pharmaceuticals, Inc. (ACUR) - Yahoo Finance
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

ACUR Stock Analysis - Frequently Asked Questions

Acura Pharmaceuticals' stock was trading at $0.0002 on January 1st, 2025. Since then, ACUR stock has increased by 0.0% and is now trading at $0.0002.

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) issued its quarterly earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 earnings per share (EPS) for the quarter. The specialty pharmaceutical company earned $1.32 million during the quarter.

Acura Pharmaceuticals subsidiaries include Acura Pharmaceutical Technologies Inc..

Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Ekso Bionics (EKSO), VIVUS (VVUS), Corbus Pharmaceuticals (CRBP), Fulcrum Therapeutics (FULC) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Last Earnings
2/28/2020
Today
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ACUR
Previous Symbol
NASDAQ:ACUR
Employees
10
Year Founded
1935

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
53,066,000
Market Cap
$13.30 thousand
Optionable
Not Optionable
Beta
-2.43

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTCMKTS:ACUR) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners